These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course. Chen XF; Yeong J; Chang KTE; Lim AST; Kuick CH; Lim TH; Sudhanshi J; Selvarajan S; Gan VHL; Khor LY Ann Clin Lab Sci; 2018 Jan; 48(1):110-115. PubMed ID: 29531006 [TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314 [TBL] [Abstract][Full Text] [Related]
24. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma. Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565 [TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical study of perivascular epithelioid cell neoplasms]. Xia QY; Rao Q; Shen Q; Liu B; Li L; Shi QL; Shi SS; Yu B; Zhang RS; Ma HH; Lu ZF; Wang X; Tu P; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):381-5. PubMed ID: 24060071 [TBL] [Abstract][Full Text] [Related]
26. The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma. Liu N; Guo W; Shi Q; Zhuang W; Pu X; Chen S; Qu F; Xu L; Zhao X; Li X; Zhang G; Guo H; Gan W; Li D Sci Rep; 2020 Oct; 10(1):16361. PubMed ID: 33004995 [TBL] [Abstract][Full Text] [Related]
27. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article. Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679 [TBL] [Abstract][Full Text] [Related]
28. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features. Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724 [TBL] [Abstract][Full Text] [Related]
29. Sinonasal Melanotic PEComa With NONO::TFE3 Fusion : A Case Report and Letter to the Editor. Shah AA; Wang S; Shires C; Johnston GA; Billings SD Am J Surg Pathol; 2024 May; 48(5):634-636. PubMed ID: 38446114 [No Abstract] [Full Text] [Related]
30. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene. Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953 [TBL] [Abstract][Full Text] [Related]
31. PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue. Xiong L; Chen X; Liu N; Wang Z; Miao B; Gan W; Li D; Guo H PLoS One; 2017; 12(9):e0185337. PubMed ID: 28949976 [TBL] [Abstract][Full Text] [Related]
33. ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma? Chai J; Ma J; Liu Y; Zhao D; Yin Z; Wang Z; Fan L Pathology; 2023 Apr; 55(3):416-419. PubMed ID: 36104270 [No Abstract] [Full Text] [Related]
34. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422 [TBL] [Abstract][Full Text] [Related]
35. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms. Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365 [TBL] [Abstract][Full Text] [Related]
36. TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica. Hyrcza MD; Winer DA; Shago M; Au K; Zadeh G; Asa SL; Mete O Endocr Pathol; 2017 Mar; 28(1):22-26. PubMed ID: 27189222 [TBL] [Abstract][Full Text] [Related]